Need a specific person's email?
Browse Smart Immune's employee directory (about 12 employees) and reveal verified emails free.
Smart Immune's most common email format is First.Last@smart-immune.com (ex. John.Doe@smart-immune.com), used for 94% of smart-immune.com addresses. Smart Immune uses 3 email patterns.
| Format | Example | Share of smart-immune.com |
|---|---|---|
| First.Last@smart-immune.comMost common | John.Doe@smart-immune.com | |
| FirstLast@smart-immune.com | JohnDoe@smart-immune.com | |
| First.Middle@smart-immune.com | John.Michael@smart-immune.com |
Browse Smart Immune's employee directory (about 12 employees) and reveal verified emails free.
Biotechnology ResearchÎle-de-France, France11-50 Employees
Smart Immune is a clinical-stage biotechnology company based in Paris, within the Île-de-France region, focused on developing ProTcell, a thymus-empowered T cell progenitor platform. The aim is to rapidly re-arm the immune system to treat cancer and infectious disease, enabling next-generation allogeneic T cell therapies. The company collaborates with leading institutions in the United States and Europe to advance its programs. Its lead program, SMART101, is in Phase I/II trials for cancers such as AML and ALL, and for SCID in both the EU and the US. Smart Immune is pursuing therapies based on gene-modified T cell progenitors to support off-the-shelf T cell treatment options. In December 2023, the company appointed Dr. Rahim Fandi as Chief Medical Officer, reflecting ongoing clinical development activity.
Most common format
First.Last@smart-immune.com
Example: John.Doe@smart-immune.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.